I am a
Home I AM A Search Login

Papers of the Week


Papers: 22 Aug 2020 - 28 Aug 2020


Animal Studies, Pharmacology/Drug Development


2020 Aug 27


Br J Pharmacol

TREK-1 channel activation as a new analgesic strategy devoid of opioid adverse effects.

Authors

Busserolles J, Ben Soussia I, Pouchol L, Marie N, Meleine M, Devilliers M, Judon C, Schopp J, Clémenceau L, Poupon L, Chapuy E, Richard S, Noble F, Lesage F, Ducki S, Eschalier A, Lolignier S
Br J Pharmacol. 2020 Aug 27.
PMID: 32851651.

Abstract

Opioids are effective painkillers. However, their risk-benefit ratio is dampened by numerous adverse effects and opioid misuse has led to a public health crisis. Safer alternatives are required but isolating the antinociceptive effect of opioids from their adverse effects is a pharmacological challenge because activation of the mu opioid receptor triggers both the antinociceptive and adverse effects of opioids.